Retatrutide
Retatrutide is referenced in metabolic research literature as a triple agonist peptide framework targeting GLP-1, GIP, and glucagon receptor pathways in preclinical models. VaultLabs catalogs GLP-3 RT 10mg as the research material designation.
Research use only. For in vitro research use only. Not for human or animal consumption. Not for human consumption, medical use, or personal application.
Last updated: 2026-06-01
Overview
Retatrutide is referenced in metabolic research literature as a triple agonist peptide framework targeting GLP-1, GIP, and glucagon receptor pathways in preclinical models. VaultLabs catalogs GLP-3 RT 10mg as the research material designation.
Key facts
Compound type: Multi-receptor agonist peptide (research literature)
Form: Lyophilized powder
Appearance: White to off-white lyophilized material
Synonyms
GLP-3 RT · LY3437943 · Triple agonist peptide (research literature)
Research interest areas
Receptor binding assays
Glucose homeostasis models (preclinical)
Energy expenditure literature reviews
In vitro receptor pharmacology
Storage information
2–8 °C (lyophilized, sealed)
2–8 °C · protect from light. Use temperature-aware UAE dispatch and immediate laboratory storage on receipt.
Stability notes
Peptide agonists require strict cold chain and minimal exposure. Verify integrity via COA HPLC before long-term study incorporation.
References
- Metabolic pathway research literature — in vitro and preclinical contexts.